Vibhuti Srivastava, BS, MS, PHD
School of Health Professions, Division of Education & Training
About Dr. Vibhuti Srivastava
Present Title & Affiliation
Primary Appointment
Assistant Professor, Associate Program Director, Department of School of Health Professions, Division of Education & Training, UT MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2008 | University Of Delhi, Delhi, IN, Molecular Genetics, PhD |
| 2002 | University Of Delhi, Delhi, IN, Zoology, Molecular Biology, MS |
Postgraduate Training
| 2011-2014 | Post-doctoral fellow, UT MD Anderson Cancer Center, Houston, Texas |
| 2008-2011 | Post-doctoral fellow, Genetics and Genomics, National Institutes of Health (NIH), Rockville, MD |
Experience & Service
Administrative Appointments/Responsibilities
Associate Program Director, Department of School of Health Professions, UT MD Anderson Cancer Center, Houston, Texas, 2022 - Present
Other Appointments/Responsibilities
Education Coordinator, Molecular Genetic Technology, UT MD Anderson Cancer Center, Houston, Texas, 2021 - 2022
Contractor, Molecular Genetic Technology, UT MD Anderson Cancer Center, Houston, Texas, 2020 - 2021
Senior Health Professions Educator, Molecular Genetic Technology, UT MD Anderson Cancer Center, Houston, Texas, 2014 - 2017
Lecturer, Molecular Biology, Zoology, Delhi University, Delhi, Delhi, 2007 - 2008
Institutional Committee Activities
Member, Academic Review Committee for the Division of Education & Training, 2023 - Present
Member, Junior Faculty Committee, 2023 - Present
Member, Academic Affairs Committee (AAC), 2022 - Present
Member, Student Learning Outcomes (SLO) Assessment Committee, 2022 - Present
Member, Cancer Genomics Consortium (CGC): Early Career Initiative Committee, 2022 - Present
Member, School of Health Professions Interdisciplinary Case Studies (IDCS) team, 2021 - Present
Member, School of Health Professions MGT Admissions Committee, 2015 - Present
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Gitik M, Srivastava V, Hodgkinson CA, Shen PH, Goldman D, Meyerhoff DJ. Association of Superoxide Dismutase 2 (SOD2) Genotype with Gray Matter Volume Shrinkage in Chronic Alcohol Users: Replication and Further Evaluation of an Addiction Gene Panel. Int J Neuropsychopharmacol 19(9):pyw033, 2016. PMID: 27207918.
- Fujii S, Srivastava V, Hegde A, Kondo Y, Shen L, Hoshino K, Gonzalez Y, Wang J, Sasai K, Ma X, Katayama H, Estecio MR, Hamilton SR, Wistuba I, Issa JP, Sen S. Regulation of AURKC expression by CpG island methylation in human cancer cells. Tumor Biol 6(10):8147-58, 2015. PMID: 25990457.
- Kukshal P, Kodavali VC, Srivastava V, Wood J, McClain L, Bhatia T, Bhagwat AM, Deshpande SN, Nimgaonkar VL, Thelma BK. Dopaminergic gene polymorphisms and cognitive function in a north Indian schizophrenia cohort. J Psychiatr Res 47(11):1615-22, 2013. PMID: 23932573.
- Hodgkinson CA, Enoch MA, Srivastava V, Cummins-Oman JS, Ferrier C, Iarikova P, Sankararaman S, Yamini G, Yuan Q, Zhou Z, Albaugh B, White KV, Shen PH, Goldman D. Genome-wide association identifies candidate genes that influence the human electroencephalogram. Proc Natl Acad Sci U S A 107(19):8695-700, 2010. PMID: 20421487.
- Srivastava V, Buzas B, Momenan R, Oroszi G, Pulay AJ, Enoch MA, Hommer DW, Goldman D. Association of SOD2, a mitochondrial antioxidant enzyme, with gray matter volume shrinkage in alcoholics. Neuropsychopharmacology 35(5):1120-8, 2010. PMID: 20043000.
- Srivastava V, Deshpande SN, Thelma BK. Dopaminergic pathway gene polymorphisms and genetic susceptibility to schizophrenia among north Indians. Neuropsychobiology 61(2):64-70, 2010. PMID: 20016224.
- Hong LE, Hodgkinson CA, Yang Y, Sampath H, Ross TJ, Buchholz B, Salmeron BJ, Srivastava V, Thaker GK, Goldman D, Stein EA. A genetically modulated, intrinsic cingulate circuit supports human nicotine addiction. Proc Natl Acad Sci U S A 107(30):13509-14, 2010. PMID: 20643934.
- Thomas P, Srivastava V, Singh A, Mathur P, Nimgaonkar VL, Lerer B, Thelma BK, Deshpande SN. Correlates of response to Olanzapine in a North Indian Schizophrenia sample. Psychiatry Res 161(3):275-83, 2008. PMID: 19000940.
- Srivastava V, Deshpande SN, Nimgaonkar VL, Lerer B, Thelma B. Genetic correlates of olanzapine-induced weight gain in schizophrenia subjects from north India: role of metabolic pathway genes. Pharmacogenomics 9(8):1055-68, 2008. PMID: 18681781.
- Srivastava V, Varma PG, Prasad S, Semwal P, Nimgaonkar VL, Lerer B, Deshpande SN, BK T. Genetic susceptibility to tardive dyskinesia among schizophrenia subjects: IV. Role of dopaminergic pathway gene polymorphisms. Pharmacogenet Genomics 16(2):111-7, 2006. PMID: 16424823.
Other Articles
- Huang JT, Wang J, Srivastava V, Sen S, Liu SM MicroRNA Machinery Genes as Novel Biomarkers for Cancer. Front Oncol 4(None):113, 2014. PMID: 24904827.
- Srivastava V, Sen S Genetic variation in coding region of Aurora kinase A gene leads to cancer susceptibility. Cancer Epidemiol 38(2):109-10, 2014. PMID: 24685408.
- Thelma B, Srivastava V, Tiwari AK Genetic underpinnings of tardive dyskinesia: passing the baton to pharmacogenetics. Pharmacogenomics 9(9):1285-306, 2008. PMID: 18781856.
Book Chapters
- Srivastava V, Goldman D. Imaging genetics and addictions. In: Neuroimaging in the Addictions. None. John Wiley and Sons, 287-317, 2011.
Patient Reviews
CV information above last modified September 18, 2024